Cargando…
非小细胞肺癌EGFR基因靶向治疗研究进展
Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) have brought great clinical benefit to patients with EGFR-sensitive mutations. With the deepening of clinical and basic research, EGFR-TKIs have received more and more attention. In this review, we summarize the latest research...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
中国肺癌杂志编辑部
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5973286/ https://www.ncbi.nlm.nih.gov/pubmed/28103975 http://dx.doi.org/10.3779/j.issn.1009-3419.2017.01.09 |
_version_ | 1783326584120279040 |
---|---|
collection | PubMed |
description | Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) have brought great clinical benefit to patients with EGFR-sensitive mutations. With the deepening of clinical and basic research, EGFR-TKIs have received more and more attention. In this review, we summarize the latest research development about EGFR-targeted drugs in 2016. |
format | Online Article Text |
id | pubmed-5973286 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | 中国肺癌杂志编辑部 |
record_format | MEDLINE/PubMed |
spelling | pubmed-59732862018-07-06 非小细胞肺癌EGFR基因靶向治疗研究进展 Zhongguo Fei Ai Za Zhi 综述 Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) have brought great clinical benefit to patients with EGFR-sensitive mutations. With the deepening of clinical and basic research, EGFR-TKIs have received more and more attention. In this review, we summarize the latest research development about EGFR-targeted drugs in 2016. 中国肺癌杂志编辑部 2017-01-20 /pmc/articles/PMC5973286/ /pubmed/28103975 http://dx.doi.org/10.3779/j.issn.1009-3419.2017.01.09 Text en 版权所有©《中国肺癌杂志》编辑部2017 https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 3.0) License. See: https://creativecommons.org/licenses/by/3.0/ |
spellingShingle | 综述 非小细胞肺癌EGFR基因靶向治疗研究进展 |
title | 非小细胞肺癌EGFR基因靶向治疗研究进展 |
title_full | 非小细胞肺癌EGFR基因靶向治疗研究进展 |
title_fullStr | 非小细胞肺癌EGFR基因靶向治疗研究进展 |
title_full_unstemmed | 非小细胞肺癌EGFR基因靶向治疗研究进展 |
title_short | 非小细胞肺癌EGFR基因靶向治疗研究进展 |
title_sort | 非小细胞肺癌egfr基因靶向治疗研究进展 |
topic | 综述 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5973286/ https://www.ncbi.nlm.nih.gov/pubmed/28103975 http://dx.doi.org/10.3779/j.issn.1009-3419.2017.01.09 |
work_keys_str_mv | AT fēixiǎoxìbāofèiáiegfrjīyīnbǎxiàngzhìliáoyánjiūjìnzhǎn AT fēixiǎoxìbāofèiáiegfrjīyīnbǎxiàngzhìliáoyánjiūjìnzhǎn |